Mutagenicity

Chemical hazard endpoint describing the potential to cause genetic mutations, driving germ cell mutagenicity classification, labeling, and regulatory restriction.

Foresight tracks Mutagenicity developments and surfaces the alerts most likely to matter before they turn into missed deadlines, recalls, or escalation work.

Current activity

Cooling

32% below the prior 8-week baseline

3-month trend

Latest alerts below

Last updated

5 April 2026, 05:08

Jump to alerts

Latest Mutagenicity alerts

The most recent regulatory and guidance signals tracked by Foresight

ECHA Receives CLH Submission for (Benzyloxy)Methanol

Austria submitted a formal proposal to ECHA in March 2026 to classify (benzyloxy)methanol as a Category 1B carcinogen and Category 2 mutagen. This move triggers significant regulatory risk for biocidal applications, potentially leading to market exclusions and mandatory hazard labeling for downstream chemical mixtures.

echa.europa.euEuropean UnionEuropean Union

Canada: Waivers Granted for Certain New-Substance Information Requirements Under CEPA 1999

Canada has issued case-by-case waivers for specific new-substance data requirements, exempting notified substances from certain toxicity and physical-chemical testing. This demonstrates the continued application of regulatory flexibility for market entrants, allowing for reduced compliance costs when specific data is deemed unnecessary for risk assessment.

gazette.gc.caCanadaCanada

European Parliament EMPL Committee To Hold Electronic Vote On Proposal Amending Directive 2004/37/EC

The European Parliament's EMPL Committee will vote on the CMRD 6 proposal on 15 April 2026, advancing the process to set new occupational exposure limits for hazardous substances. This step signals the transition to final interinstitutional negotiations, requiring businesses to monitor upcoming compliance obligations for workplace chemical safety.

europarl.europa.euEuropean UnionEuropean Union

EU SCCS Publishes Minutes of Nanomaterials Working Group Meeting on TiO2 and Synthetic Amorphous Silica

The EU SCCS is finalizing safety assessments for titanium dioxide and synthetic amorphous silica (nano) while updating nanomaterial guidance. Manufacturers face potential exclusion of specific TiO2 clusters from future approvals and stricter default safety assumptions for silica if data gaps are not addressed.

health.ec.europa.euEuropean UnionEuropean Union

EU Commission To Prepare Article 55(3) Derogations For Ethylene Oxide In Archive Protection By June 2026

The European Commission aims to finalize Article 55(3) derogations for ethylene oxide use in archive protection by June 2026. This highlights the extremely narrow scope for continued use of this high-risk substance, reinforcing the need for industry to prioritize alternatives for all but the most essential applications.

circabc.europa.euEuropean UnionEuropean Union

ECHA Opens Consultation On 54 REACH Testing Proposals (Deadline 8 May 2026)

ECHA has launched a public consultation on 54 new REACH testing proposals for vertebrate studies, covering 32 substances including vanadium compounds, petroleum residues, and complex amides. Companies should review the proposed endpoints—ranging from reproductive toxicity to bioaccumulation—to provide existing data or non-animal alternatives by 8 May 2026 to avoid unnecessary testing costs and animal use.

echa.europa.euEuropean UnionEuropean Union

EMA Adopts Revised Guideline on the Chemistry of Active Substances for Human Medicines

The EMA has revised its guideline on the chemistry of active substances for human medicines, with new requirements taking effect in September 2026. Companies must implement more rigorous impurity control strategies—specifically for nitrosamines—and provide deeper technical justification for starting materials and solvent recovery processes.

ema.europa.euEuropean UnionEuropean Union

RIVM Researchers Publish Review on Epigenotoxicity and Regulatory Genetic Toxicology

RIVM and international experts have published a consensus review proposing the integration of epigenotoxicity data into standard regulatory genetic toxicology frameworks. This signals a long-term shift toward more sensitive testing requirements that could identify non-genotoxic carcinogens and transgenerational risks currently missed by standard assays.

pubmed.ncbi.nlm.nih.govNetherlandsNetherlands

Czech SZPI Flags Tesco Finest Avocado Oil Batch Over Glycidol Contamination

Czech authorities have flagged specific batches of avocado oil as unsafe due to glycidol contamination, a process contaminant formed during refining. This enforcement action highlights increasing scrutiny on process-induced contaminants in refined oils, necessitating stricter supply chain quality controls and refining process monitoring.

potravinynapranyri.czCzechiaCzechia

ECHA Opens CLH Consultations On Hydrochloric Acid And Sulphuryl Difluoride

ECHA has launched public consultations on harmonised classification and labelling (CLH) for hydrochloric acid and sulphuryl difluoride, closing May 18, 2026. Proposed classifications for CMR and acute toxicity hazards will mandate labelling updates and may trigger broader downstream restrictions for industrial and biocidal applications.

echa.europa.euEuropean UnionEuropean Union

EU SCCS Methodologies Working Group Minutes Highlight Aggregate Exposure and Notes of Guidance Revision

The SCCS is progressing on a harmonised aggregate exposure framework and the 13th revision of its Notes of Guidance for cosmetic safety. Manufacturers should anticipate more complex exposure modeling requirements and updated toxicological assessment protocols for future product dossiers.

health.ec.europa.euEuropean UnionEuropean Union

Romania CES Backs Draft Government Decision Amending Worker Protection for Carcinogenic and Chemical Agents

Romania is advancing a draft decree to update national occupational safety and health (OSH) standards for carcinogenic and chemical agents. Businesses should anticipate revised exposure limits and stricter workplace controls as Romania aligns with updated EU-wide worker protection requirements.

ces.roRomaniaRomania

ECHA Records 06 March 2026 RAC Opinion Date for Sodium Bromate

ECHA's Risk Assessment Committee (RAC) adopted an opinion in March 2026 supporting the harmonised classification of sodium bromate as a Category 1B carcinogen. This move initiates the transition toward mandatory labelling updates and potential downstream restrictions for products containing the substance.

echa.europa.euEuropean UnionEuropean Union

ECHA Changes CoRAP Evaluation Status To Ongoing For Substance CAS 57583-34-3

ECHA has activated the formal substance evaluation for a high-tonnage organotin compound (CAS 57583-34-3) under the REACH Community Rolling Action Plan. Companies should monitor this assessment closely, as confirmed CMR concerns typically lead to stringent downstream restrictions or harmonized classification requirements.

echa.europa.euEuropean UnionEuropean Union

United States Notifies WTO of EPA TSCA Risk Evaluation for 1,3-Butadiene

The US EPA has finalized the TSCA risk evaluation for 1,3-butadiene, concluding that the substance poses unreasonable risks to human health under several conditions of use. This determination mandates the initiation of risk management rulemaking, signaling forthcoming regulatory restrictions or stringent exposure limits for the chemical and its downstream applications.

federalregister.govUnited StatesUnited States

Great Britain HSE Consults On Identifying TBNPA As SVHC Under UK REACH

The UK HSE has proposed identifying the flame retardant TBNPA as a Substance of Very High Concern (SVHC), with a consultation open until April 17, 2026. SVHC designation will trigger mandatory supply chain communication and notification duties for articles containing the substance, while signaling a likely path toward future authorization requirements.

consultations.hse.gov.ukUnited KingdomUnited Kingdom

Germany Notifies Harmonised Classification Intention for 4‑Dimethylaminoazobenzene

Germany has initiated the process to classify 4-dimethylaminoazobenzene as a Category 1B carcinogen and Category 2 mutagen, with a formal dossier expected by September 2026. This classification would trigger mandatory hazard labeling updates and likely lead to automatic restrictions in consumer-facing products under REACH and sector-specific safety laws.

echa.europa.euEuropean UnionEuropean UnionGermanyGermany

EU EFSA Publishes Safety Assessment of Poly(2-ethyl-2-oxazoline) for Use in Plastic Food-Contact Filter Membranes

EFSA has issued a positive safety opinion for Poly(2-ethyl-2-oxazoline) in plastic food-contact filter membranes, clearing a key technical hurdle for its formal EU authorization. Companies should monitor for subsequent amendments to the Plastics Regulation (EU) 10/2011, noting specific concentration limits and exclusions for infant-related applications.

doi.orgEuropean UnionEuropean Union

CJEU Appeal Challenges CLP Delegated Regulation (EU) 2024/197 on Dibutyltin Oxide (Case C-829/25 P)

A legal appeal has been lodged with the CJEU challenging the harmonized classification of dibutyltin oxide under the CLP Regulation (EU) 2024/197. While the appeal creates long-term legal uncertainty, businesses must maintain compliance with the existing mandatory classification requirements effective since September 2025.

eur-lex.europa.euEuropean UnionEuropean Union

HEAL Submits Feedback To EU Call For Evidence On Biocidal Products Regulation Evaluation

The Health and Environment Alliance (HEAL) has submitted formal feedback to the EU’s Biocidal Products Regulation (BPR) evaluation, advocating for stricter enforcement of hazard-based exclusion criteria. This signals intensifying NGO pressure for faster phase-outs of legacy substances and more rigorous data requirements for endocrine disruptors, potentially leading to tighter market access and labeling rules for biocidal products.

env-health.orgEuropean UnionEuropean Union

Not a newsletter. Not a feed. Structured intelligence mapped to your business.

These are just a few of the most recent Mutagenicity alerts. Foresight tracks every jurisdiction, every day — and surfaces only what affects your portfolio, with full citations and evidence.

Book a demo

Frequently asked questions

Everything you need to know about Foresight's regulatory intelligence platform

Still have questions? Get in touch with our team

Join 3,500+ professionals staying ahead

Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.

Free forever. Unsubscribe anytime.

Read by professionals at

Boeing
AstraZeneca
Siemens
PepsiCo
SpaceX
Mutagenicity regulatory monitoring | Foresight®